Breast cancer risk assessment: Use of complete pedigree information and the effect of misspecified ages at diagnosis of affected relatives

Human Genetics

Volumn 102, Issue 3, 1998, Pages 348-356

  Schmidt, Silke ^a   Becher, Heiko ^a   Chang Claude, Jenny ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; FEMALE; GENE MUTATION; GENEALOGY; GENETIC COUNSELING; GENETIC MODEL; GENETIC RISK; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; ONSET AGE; PRIORITY JOURNAL; RELATIVE; RISK ASSESSMENT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, TUMOR SUPPRESSOR; HETEROZYGOTE; HUMANS; INTERPERSONAL RELATIONS; LIKELIHOOD FUNCTIONS; MIDDLE AGED; PEDIGREE; RISK ASSESSMENT;

EID: 0031923083     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390050704     Document Type: Article

References (21)

1. Becher H, Chang-Claude J (1996) Estimation of population specific individual disease risks for a given family history with an application to breast cancer. Genet Epidemiol 13:229-242
2. Berry DA, Parmigiani G, Sanchez J, Schildkraut J, Winer E (1997) Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst 89:227-238
3. Chang-Claude J, Becher H, Eby N, Basiert G, Wahrendorf J, Hamann U (1997) Modifying effect of reproductive risk factors on the age at onset of breast cancer for German BRCA1 mutation carriers. J Cancer Res Clin Oncol 123:272-279
4. Chang-Claude J, Dong J, Schmidt S, Shayeghi M, Komitowski D, Becher H, Stratton M, Royer-Prokora B (1998) Using gene carrier probability to select high-risk families for identifying germline mutations in breast cancer susceptibility genes. J Med Genet (in press)
5. Claus EB, Risch NJ, Thompson WD (1991) Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am J Hum Genet 48:232-242
6. Claus EB, Risch N, Thompson WD (1994) Autosomal dominant inheritance of early-onset breast cancer. Cancer 73:643-651
7. Easton DF (1996) Communication at the European Breast Cancer Linkage Consortium Meeting, October 10-11, 1996, Lyon, France
8. Easton DF, Bishop DT, Ford D, Crockford GP, the Breast Cancer Linkage Consortium (1993) Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 52:678-701
9. Easton DF, Ford D, Bishop DT, the Breast Cancer Linkage Consortium (1995) Breast and ovarian cancer incidence in BRCAl-mutation carriers. Am J Hum Genet 56:265-271
10. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ (1989) Projecting individualized probabilities of breast cancer for white females who are being examined annually. J Nat Cancer Inst 81:1879-1886
11. Hoskins KF, Stopfer JE, Calzone KA, Merajver SD, Rebbeck TR, Garber JE, Weber BL (1995) Assessment and counseling for women with a family history of breast cancer. J Am Med Assoc 273:577-585
12. Lathrop GM, Lalouel J-M, Julier C, Ott J (1984) Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci USA 1:3443-3446
13. Margarine-Jeannin P, Essioux L, Bonaiti-Pellié C, Clerget-Darpoux F (1995) Genetic counseling in breast cancer: sensitivity to parameter values and to available information. Ann Genet 38:19-25
14. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71
15. Narod SA, Goldgar D, Cannon-Albright L, Weber B, Moslehi R, Ives E, Lenoir G, Lynch H (1995) Risk modifiers in carriers of BRCA1 mutations. Int J Cancer 64:394-398
16. Ott J (1991) Analysis of human genetic linkage, revised edn. The Johns Hopkins University Press, Baltimore
17. Parmigiani G, Berry DA, Aguilar O (1997) Determining carrier probabilities for breast cancer susceptibility genes BRCA1 and BRCA2. Duke Institute of Statistics and Decision Sciences Discussion Paper 97-34 (available via Internet at http://www.isds.duke.edu, link to "Discussion Papers")
18. Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, Hoskins K, et al (1995) A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene - implications for presymptomatic testing and screening. J Am Med Assoc 273:535-541
19. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, Me Adams M, Timmerman MM, Brody LC, Tucker MA (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401-1408
20. Whittemore AS, Gong G, Itnyre J (1997) Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three US population-based case-control studies of ovarian cancer. Am J Hum Genet 60: 496-504
21. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, et al (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792